课题基金 / 基金详情

Effect zoledronic acid and risedronate on the preservation of the femoral head in a rat model of Perthes disease

Effect zoledronic acid and risedronate on the preservation of the femoral head in a rat model of Perthes disease
唑来膦酸和利塞膦酸钠对Perthes病大鼠模型股骨头保存的影响
批准号:
nhmrc : 249400
负责人:
Dr Claire Cooke-Yarborough
金额:
$13.32万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2005-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Perthes Disease (Legg-Perthes Disease) is a common childhood disorder, which leads to collapse and deformity of the growing hip joint. This can lead to arthritis in adult life, as well as a short leg on the affected side. The cause is as yet unknown. A class of drugs called bisphosphonates has been shown to help children with osteogenesis imperfecta (brittle bone disease). We believe, based on our extensive studies of the effect of these drugs on bone healing, that they could also help children with Perthes disease. Although proving to be safe and effective in children with osteogenesis imperfecta, before exposing children with Perthes disease to the risk of any side effects, animal studies are needed. A certain type of rat called the spontaneously hypertensive rat gets a condition almost exactly the same as Perthes disease. This study will treat a large number of these rats and perform detailed study into whether it has a positive effect on preserving the shape of the hip joint, as well as looking into how this actually occurs. A successful outcome would pave the way for trials in children with Perthes disease, and could result in the avoidance of surgery and improved health outcomes for the children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Zoledronic Acid 的介孔二氧化硅微球/羟基磷灰石/生物玻璃涂层的促骨折愈合作用及其机制研究